GB1214712A - Contraceptive preparations - Google Patents
Contraceptive preparationsInfo
- Publication number
- GB1214712A GB1214712A GB9347/68A GB934768A GB1214712A GB 1214712 A GB1214712 A GB 1214712A GB 9347/68 A GB9347/68 A GB 9347/68A GB 934768 A GB934768 A GB 934768A GB 1214712 A GB1214712 A GB 1214712A
- Authority
- GB
- United Kingdom
- Prior art keywords
- preparation
- gestagen
- oestrogen
- feb
- contraceptive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1,214,712. Contraceptive preparation. SCHBRING A.G. 27 Feb., 1968 [28 Feb., 1967], No. 9347/68. Heading A5B. A contraceptive preparation suitable for parenteral administration or administration by implantation comprises, in unit dosage form, from 0.5 'to 100 mg. of a gestagen in admixture or conjunction with from 0.5 to 500 mg. of an oestrogen. The preparation may be used to treat domestic animals and the oestrogen and the gestagen may be administered simultaneously or separately. Many suitable oestrogens and gestagens are specified.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESC040314 | 1967-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1214712A true GB1214712A (en) | 1970-12-02 |
Family
ID=7435619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9347/68A Expired GB1214712A (en) | 1967-02-28 | 1968-02-27 | Contraceptive preparations |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE711395A (en) |
DE (1) | DE1617837A1 (en) |
FR (1) | FR7537M (en) |
GB (1) | GB1214712A (en) |
NL (1) | NL6802706A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US7459445B2 (en) | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
-
1967
- 1967-02-28 DE DE19671617837 patent/DE1617837A1/en active Pending
-
1968
- 1968-02-17 FR FR141398A patent/FR7537M/fr not_active Expired
- 1968-02-26 NL NL6802706A patent/NL6802706A/xx unknown
- 1968-02-27 GB GB9347/68A patent/GB1214712A/en not_active Expired
- 1968-02-28 BE BE711395D patent/BE711395A/xx unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US6844334B2 (en) | 2000-03-10 | 2005-01-18 | Endeavor Pharmaceuticals | (3) and (6) substitued estrogenic compounds |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US7179799B2 (en) | 2000-03-10 | 2007-02-20 | Barr Laboratories, Inc. | (3) and (6) substituted estrogenic compounds |
US7459445B2 (en) | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US7749989B2 (en) | 2000-03-10 | 2010-07-06 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds, methods of using and methods of administering the same |
US8227454B2 (en) | 2000-03-10 | 2012-07-24 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds, pharmaceutical compositions and formulations comprising the same |
US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
Also Published As
Publication number | Publication date |
---|---|
BE711395A (en) | 1968-08-28 |
FR7537M (en) | 1969-12-22 |
NL6802706A (en) | 1968-08-29 |
DE1617837A1 (en) | 1971-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1490099A (en) | Contraceptive method and pack | |
ATE114116T1 (en) | CONTINUOUS ADMINISTRATION OF LUTEINIZING HORMONE-RELEASING HORMONE IN COMBINATION WITH SEXSTEROID ADMINISTRATION AS A CONTRACEPTIVE METHOD. | |
GB1433032A (en) | Contraceptive method and preparations | |
MX9804395A (en) | Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen. | |
DE69710896T2 (en) | PROGESTOGEN-ANTI-PROGESTOGEN THERAPIES | |
KR920011514A (en) | Contraceptives containing only progestogens | |
Friesen | Lactation induced by human placental lactogen and cortisone acetate in rabbits | |
SE7711102L (en) | NEW MEASURES AND NEW WAYS TO TREAT CLIMATE ACTIVITY SYMPTOMS | |
GB1214712A (en) | Contraceptive preparations | |
GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
GB1231412A (en) | ||
Howie | The progestogen-only pill | |
Nutting et al. | Anabolic-androgenic activity of A-ring modified androstane derivatives. Part I: A comparison of parenteral activity | |
Sharaf et al. | Phytoestrogens and their antagonism to progesterone and testosterone | |
Goldzieher et al. | Seven years of clinical experience with a sequential oral contraceptive | |
FR2097045A1 (en) | 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders | |
GB1218648A (en) | Improvements in hay rolls | |
Greenblatt | Oral contraceptives: the state of the art | |
GB1180574A (en) | Improvements in or relating to Injectable Thyroxine Preparations | |
GB1459485A (en) | Medicament pack for the oral treatment with oestrogen | |
Robson | Failure to antagonize the action of oestradiol on the corpus luteum by progesterone or testosterone | |
Kabiraj et al. | Effects of hysterectomy, administration of uterine extract, posterior pituitary extract and aspirin on the length of pseudopregnancy in rats | |
GB1311680A (en) | Contraceptive preparations and method of contraception | |
Utsumi et al. | Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B) | |
Velasquez et al. | URINARY EXCRETION OF GONADOTROPINS IN CATTLE SUFFERING FROM CANCER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PLNP | Patent lapsed through nonpayment of renewal fees |